A company started by former executives from Kite Pharma has raised $120 million to develop the next generation of CAR-T therapies.
SUBSCRIBE
Biohealth Innovation
Founding Member of
Biohealth Innovation
A company started by former executives from Kite Pharma has raised $120 million to develop the next generation of CAR-T therapies.